Vicore, Bioinvent, Hofseth – Strong Day For Scandi Pharma

Vicore, Bioinvent and Hofseth all reported positive news today. Vicore Pharma Vicore Pharma is the global leader in Idiopathic pulmonary fibrosis (IPF). IPF is a condition in which the lungs become scarred, and breathing becomes increasingly difficult. Vicore has the best-ever results in their study. This year, the company is planning its 2B study, which may beContinue reading “Vicore, Bioinvent, Hofseth – Strong Day For Scandi Pharma”

Top Ideas for 2024

Our top ideas for the coming year. Our family office has a position in all the below. Golar LNG Golar LNG Limited  For the full investment idea summary, go: Africa Oil Africa oil At 19 SEK/sh, the Venus discovery/ Namibia exposure either is not reflected in the share price at all, or ii) Venus isContinue reading “Top Ideas for 2024”

Biovica – CEO Invests 10 mil NOK, Progress on All Fronts

CEO of Biovica: “I have invested 10 Mil NOK in the capital raise”“Our US team invested most of their bonuses into the capital raise. This was a great sign of confidence for me” Important CEO quotes from the report: Quarterly report: Presentation and Webcast https://biovica.com/investor-relations/financial-reports/#english Redeye Research Summary: Biovica Q2 (August to October): Confirmation aboutContinue reading “Biovica – CEO Invests 10 mil NOK, Progress on All Fronts”